Operating Lease, Right-of-Use Asset in USD of GT Biopharma, Inc. from Q4 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
GT Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q1 2024.
  • GT Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $27K, a 80.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

GT Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2024 $27K -$113K -80.7% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $53K -$112K -67.9% Dec 31, 2023 10-K 2025-02-21
Q3 2023 $87K -$103K -54.2% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $114K -$100K -46.7% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $140K -$97K -40.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $165K -$95.2K -36.6% Dec 31, 2022 10-K 2024-03-26
Q3 2022 $190K Sep 30, 2022 10-Q 2022-10-31
Q2 2022 $214K Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $237K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $260K +$260K Feb 8, 2022 10-K 2023-03-30
Q4 2020 $0 -$110K -100% Dec 31, 2020 10-K 2021-04-16
Q3 2020 $72K -$61K -45.9% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $80K -$67K -45.6% Jun 30, 2020 10-Q/A 2020-08-18
Q1 2020 $95K -$58K -37.9% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $110K +$110K Dec 31, 2019 10-K 2021-04-16
Q3 2019 $133K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $147K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $153K Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.